Summary:
Click image to enlargeA Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN) (BrigHTN)
Criteria:- Is on a stable regimen of a single background antihypertensive agent for at least 8 weeks and a second antihypertensive agent is warranted at the time of screening;
- Has a mean seated systolic blood pressure (SBP) ≥ 140 mmHG;
- Demonstrates they are able to be adherent to the study drug and their anti-hypertensive medication during a run-in period
- If taking SGLT2 inhibitor, the regimen must be stable for at least 8 weeks prior to randomization; and
- Agrees to comply with the contraception and reproduction restrictions of the study;
Qualified Participants May Receive:
Up to $600 for time and travel